Abstract
BackgroundAbatacept is a new class of biologic agent for the treatment of rheumatoid arthritis (RA) that inhibits T cell activation by binding to CD80/86. Although some clinicians feel that the...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have